Stock Code
603707.SH
ABOUT
>
Company profile
Enterprise Culture
Early Warning System
BUSINESS
>
Commercialized Products
MEDIA
>
News in NKF
CONTACT
CH / EN
Media Center
Home
>
MEDIA
>
News in NKF
All year
2025
2024
2023
News in NKF
NKF's Propofol Injectable Emulsion has been approved by the US FDA and is about to enter the US market!
2025-12-05
Learn more +
NKF's subsidiary Kindos's Dalbavancin for Injection gets FDA approval for marketing
2025-12-03
Learn more +
NKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!
Create a trustworthy pharmaceutical future together!
2025-10-21
Learn more +
NKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation
It has laid a solid foundation for future market expansion.
2025-10-17
Learn more +
NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
Continue to effectively leverage the advantages of the high-standard quality system and the integrated platform
2025-08-04
Learn more +
NKF makes its debut at CPHI Southeast Asia
It has opened up new channels for the company to penetrate the Southeast Asian and even the global market
2025-07-21
Learn more +
King-Friend will meet you in CPHI Malaysia！
Explore the infinite possibilities of the pharmaceutical industry!
2025-07-14
Learn more +
NKF's subsidiary Kindos's Hydralazine Hydrochloride Injection gets FDA approval for marketing
Strengthen and expand the international base of high-quality injectables
2025-06-09
Learn more +
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing
Continue to promote high-quality products and services to a new level
2025-05-26
Learn more +
1
2
3
